Clinical data | |
---|---|
Trade names | Demovis, Pilomin, others |
Other names | W-4540; Norethisterone acetate 3-cyclopentyl enol ether; 17α-Ethynyl-19-nortestosterone acetate 3-cyclopentyl enol ether; ENTACP; (17β)-3-(Cyclopentyloxy)-17-ethynylestra-3,5-dien-17-yl acetate |
Routes of administration | By mouth |
Drug class | Progestogen; Progestin; Progestogen ester |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.163 |
Chemical and physical data | |
Formula | C27H36O3 |
Molar mass | 408.582 g·mol−1 |
3D model (JSmol) | |
| |
|
Quingestanol acetate, sold under the brand names Demovis and Pilomin among others, is a progestin medication which was used in birth control pills but is no longer marketed.[1] It is taken by mouth.[2][3][4]
Quingestanol acetate is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone.[2][3][4] It has weak androgenic and estrogenic activity and no other important hormonal activity.[2][3][4] The medication is a prodrug of norethisterone in the body, with quingestanol and norethisterone acetate occurring as intermediates.[5][6]
Quingestanol acetate was patented in 1963 and was introduced for medical use in 1972.[7][8] It was marketed in Italy.[8]
pmid5815452
was invoked but never defined (see the help page).pmid4613534
was invoked but never defined (see the help page).pmid1137940
was invoked but never defined (see the help page).pmid3543501
was invoked but never defined (see the help page).pmid4853997
was invoked but never defined (see the help page).Marks2010
was invoked but never defined (see the help page).GWU1975
was invoked but never defined (see the help page).